Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Glaukos (GKOS) R&D In Process (2017 - 2022)

Glaukos has reported R&D In Process over the past 4 years, most recently at $10.0 million for Q2 2022.

  • Quarterly R&D In Process rose 100.0% to $10.0 million in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $15.0 million through Dec 2022, up 50.0% year-over-year, with the annual reading at $10.0 million for FY2022, 0.0% changed from the prior year.
  • R&D In Process was $10.0 million for Q2 2022 at Glaukos, up from $5.0 million in the prior quarter.
  • Over five years, R&D In Process peaked at $10.0 million in Q2 2022 and troughed at $1.5 million in Q3 2019.
  • The 3-year median for R&D In Process is $5.0 million (2021), against an average of $4.7 million.
  • The largest YoY upside for R&D In Process was 100.0% in 2022 against a maximum downside of 100.0% in 2022.
  • A 3-year view of R&D In Process shows it stood at $1.5 million in 2019, then surged by 233.33% to $5.0 million in 2021, then skyrocketed by 100.0% to $10.0 million in 2022.
  • Per Business Quant, the three most recent readings for GKOS's R&D In Process are $10.0 million (Q2 2022), $5.0 million (Q3 2021), and $5.0 million (Q2 2021).